ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy. | Pulmonary Arterial Hypertension PAH | Recruiting | Phase 1 / Phase 2 | 2026-07-22 | NCT07593027 | |
| A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Phase 1 / Phase 2 | 2026-06-29 | NCT06535412 | |
| A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary Syndrome. | Arterial Occlusive Diseases, acute coronary syndrome, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Early phase 1 | 2026-04-15 | NCT06788431 |